The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview and Recent Growth

• Strong Market Growth: The iliac stent market has shown significant growth recently, expanding from $0.95 billion in 2023 to $1.02 billion in 2024. This represents a compound annual growth rate (CAGR) of 6.9%.
• Drivers of Growth: Several factors have driven this expansion, including:
  • Global Healthcare Expansion: A broader global healthcare industry has increased the demand for medical devices, including iliac stents.
  • Increased Awareness: There is a growing awareness of minimally invasive procedures among healthcare professionals and patients.
  • Rising Incidence of Diseases: An increase in iliac artery diseases has led to more stenting procedures.
  • Improved Infrastructure: Enhanced healthcare facilities have supported the growing demand for stenting.

Future Market Projections

• Continued Growth Expected: The market is projected to grow further, reaching $1.34 billion by 2028, with a CAGR of 7%.
• Factors Driving Future Growth: Key factors contributing to this future growth include:
  • Prevalence of Peripheral Artery Diseases (PAD): As PAD becomes more common, the need for iliac stents to treat this condition is expected to rise.
  • Aging Population: A growing elderly population, more prone to arterial diseases, is likely to drive demand.
  • Rise in Diabetes: The increasing incidence of diabetes, a risk factor for arterial diseases, is also expected to fuel market growth.
  • Need for Minimally Invasive Procedures: A shift towards less invasive surgeries supports the adoption of stents.

Read More On The Iliac Stent Market Report 2024 – https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

Rising Prevalence of Peripheral Artery Diseases Fuels Market Growth

• Impact of PAD: The increasing prevalence of PAD is a significant driver for the iliac stent market. PAD affects the arteries outside the heart and brain, causing narrowing or blockages.
• Reasons for Rising PAD Cases:
  • Lifestyle Factors: Smoking, hypertension, and aging are contributing to higher PAD rates.
  • Health Conditions: Conditions like diabetes further increase the risk.
• Iliac Stenting as a Solution: Stenting is a minimally invasive and highly effective treatment for PAD, improving blood flow and preventing complications.
  • High Success Rates: The procedure is known for its effectiveness and lower risk of complications.
• Example of PAD Prevalence: According to the Society For Cardiovascular Angiography And Interventions, PAD currently affects 8-10 million Americans, with projections estimating that 19 million Americans will have PAD by 2050.

Technological Advancements and Product Approvals Boost Market Expansion

• Innovation in Stent Technologies: Companies are continuously developing new stent technologies to improve patient outcomes.
• FDA Approvals: Recent product approvals by the FDA, such as Getinge’s iCast-covered stent system, showcase innovation in the field.
  • Enhanced Safety: These newer stents offer better performance and reduce the risk of complications compared to traditional stents.
• Example of Technological Advancements: Getinge’s iCast stent, approved in 2023, exemplifies advancements in the field, reflecting a commitment to high-quality healthcare solutions.

Strategic Acquisitions Enhance Market Competitiveness

• Industry Consolidation: Major companies in the iliac stent market are expanding their portfolios through strategic acquisitions.
• Abbott Laboratories’ Acquisition: In February 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. (CSI) to enhance its vascular device offerings.
  • Integration of Advanced Technologies: This acquisition allows Abbott to incorporate CSI’s innovative atherectomy system, bolstering its presence in the vascular disease treatment market.

Market Segmentation and Regional Insights

• Market Segmentation: The iliac stent market is segmented based on:
  • Type: Self-expandable stents, balloon-expandable stents, and other types.
  • Artery Lesions: Common iliac artery lesions, severe calcified lesions, and complete obstructive lesions.
  • End-Users: Hospitals, outpatient facilities, and other end-users.
• Regional Dynamics:
  • North America: Was the largest region in the iliac stent market in 2023.
  • Asia-Pacific: Expected to be the fastest-growing region during the forecast period, driven by expanding healthcare infrastructure and increasing prevalence of PAD.

The iliac stent market is poised for substantial growth, driven by technological advancements, an aging population, and the increasing prevalence of PAD. With continuous innovation and strategic acquisitions, the market is set to expand further, offering improved treatment options for patients globally.

Request for A Sample Of The Global Iliac Stent Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15827&type=smp